The increased transcriptional activity of NRF2 encourages the reprogramming of iron homeostasis and lipid peroxidation, thus suppressing cell ferroptosis and promoting sorafenib resistance in liver cancer (Figure 6). Here, NFE2L2 is linked to liver cancer.